non-small cell lung cancer
Conditions
Interventions
Unexposed Group:No Intervention
Sponsors
Guang'anmen Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Have at least one measurable lesion defined in accordance with the RECIST Version 1.1 criteria. 2.ECOG performance status score = 2, with an expected survival of more than 3 months. 3.Achieve stable disease after receiving first-line chemotherapy for = 4 cycles; and before enrollment, the adverse events occurring during chemotherapy (except alopecia) have been assessed by the investigator as recovered to Grade 1 in accordance with CTCAE. 4.Have a score of = 5 in at least one of the following items (pain, fatigue, poor appetite) in the MD Anderson Symptom Inventory - Lung Cancer Module (MDASI-LC). 5.Patients who do not receive radiotherapy. 6.Aged 18 - 80 years old. 7.Voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Assessment of Cancer Therapy-Lung; | — |
Secondary
| Measure | Time frame |
|---|---|
| ECOG Performance Status Scale;MD Anderson Symptom Inventory-Lung Cancer module;Proportion of adverse reactions of CTCAE grade =3 among anti-tumor toxic and side effects during treatment;Progression-Free Survival (PFS) during treatment;Objective Response Rate (ORR) during treatment;Disease Control Rate (DCR) during treatment.;Overall Survival (OS) during the observation period; | — |
Countries
People's Republic of China
Contacts
Public ContactJie LI
Guang'anmen Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed